chrisvoncsefalvay/vaers-outcomes huggingface dataset:
mild-to-moderate soreness in her left arm deltoid region; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  An 85-year-old female patient received BNT162b2 (COMIRNATY), on 10Apr2022 as dose 2 (booster) single (Batch/Lot number: unknown), in left deltoid for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Manufacturer unknown, Dose number Unknown), for COVID-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Apr2022, outcome "unknown", described as "mild-to-moderate soreness in her left arm deltoid region".  Description of Event: During a telephone conversation today 14Apr2022, this family member mentioned that she received her second Pfizer Comirnaty booster vaccine at withheld on Sunday 10Apr2022 (4 days ago). She is an 85-yearold woman who describes mild-to-moderate soreness in her left arm deltoid region (where she received the Comirnaty booster vaccine). There is no bruising or discoloration. The soreness does not interfere with arm movement or usual activities. She will contact her primary care physician regarding this. Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
"little pain" at the injection site; left arm pain returned and lasted for several days; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN ("little pain" at the injection site) and PAIN IN EXTREMITY (left arm pain returned and lasted for several days) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol. Concomitant products included ROSUVASTATIN for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced INJECTION SITE PAIN ("little pain" at the injection site) and PAIN IN EXTREMITY (left arm pain returned and lasted for several days). At the time of the report, INJECTION SITE PAIN ("little pain" at the injection site) and PAIN IN EXTREMITY (left arm pain returned and lasted for several days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.
I had a runny nose, cough and fever in the beginning. I took a COVID 19 home test on June 22 and it was negative. I treated my symptoms with DAYQUIL but I was not getting any relief. I eventually lost my taste and smell and became really fatigued. I slept for most of the day on the 22nd, 23rd, and 24th. I called the doctor because I did not feel like I was getting any better. The doctor advised me that the symptoms seemed like COVID-19. I retested on June 25th and was positive. I remained tired with the cough. I would have coughing fits and feel tired. I feel like I have completely recovered from my symptoms.
difficulty breathing; trouble breathing; Initial information received on 04-Oct-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-HCP.  This case involves a 73 years old female patient who was reported with difficulty breathing; trouble breathing while receiving influenza quadrival A-B high dose hv vaccine [Fluzone high-dose quadrivalent].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Allergic asthma.  Concomitant medications included salbutamol (albuterol [Salbutamol]) for Immunisation.  On an unknown date, the patient received a  dose of suspect influenza quadrival A-B high dose hv vaccine lot number not reported via unknown route in unknown administration site (with an unknown strength, formulation, expiry date, dose, frequency) for immunization.  On an unknown date the patient developed a difficulty breathing; trouble breathing (dyspnoea) (unknown latency) following the administration of vaccine.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Recovered / Resolved on an unknown date for the event.
Patient states she had pain and limited range of motion in arm that received vaccination. Possible minimal redness at injection site. Some mild improvement next few days. Patient was evaluated by orthopedist specialist.
Rash and itching at injection site.  Rash extending to the elbow, 1 week after date of injection.
pt recvd vax; devel many active lesions from the top of head to genital area;
Fever, aches, swelling of face, redness of face, cough, weakness. Antibiotics at hosp.
Information has been received from a pharmacist concerning a patient of unknown age and gender. There was no pertinent medical history or drug reactions/allergies reported. On 04-AUG-2015 the patient was inadvertently vaccinated with an expired dose of (Oka/Merck) VARIVAX (lot #: J008443 and expiration date: 09-JUL-2015; dose, route and frequency were unspecified). No adverse effects were reported. Additional information has been requested.
Patient contracted COVID after being fully vaccinated.  No booster Cough, runny nose, anorexia, fevers, shortness of breath, dyspnea, congestion, fatigue, hypoxic, eye drainage.
Headaches with sharp cranial pain; nausea; fatigue; loss of taste; loss of appetite; This is a spontaneous report from a contactable consumer or other non hcp. A 70-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in right arm on 21Feb2021 14:00 hr (Batch/Lot Number: EN5318) as single dose for COVID-19 immunisation. Medical history included hypertension and rubber sensitivity from an unspecified date and unknown if ongoing. Concomitant medication included hydrochlorothiazide, lisinopril (LISINOPRIL HCTZ) taken for an unspecified indication, start and stop date were not reported.  It was reported patient had no COVID before or after the vaccination. The patient experienced headaches with sharp cranial pain, nausea, fatigue, loss of taste and loss of appetite. No treatment was received. The outcome of the events was not recovered.  No follow-up attempts are possible; No further information is expected.
Expired dose on 20-may-2022 was administered on 24-may-2022; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a female patient who received HAV (Havrix) (batch number G99R4, expiry date 20th May 2022) for prophylaxis.   On 24th May 2022, the patient received Havrix. On 24th May 2022, unknown after receiving Havrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 24-May-2022 Reporter's Comments: Health care professional (HCP) reported that Havrix expired on 20th May 2022 that was administered on 24th May 2022. The reporter consented to follow up.  The Vaccine Administration Facility was the same as Primary Reporter. Additional Supportive Information: The patient received Havrix vaccine that was already expired.
Two days after having vaccine, I developed a rash in the left arm wrist area then spreading to in between fingers. Now 3 weeks later, I have itchy bumps on my stomach and thighs and behind my knees. I?ve used hydrocortisone as advised by my healthcare provider.
Resident tested positive for COVID-19, on 8/9/2021. He declined quickly and passed away on 8/10/2021.
Numbness in throat, tongue, gums and lips. No difficulty breathing (no wheezing, SOB etc.). Tongue still numb today, >24 hours after administration
Given the shot one week early to a patient/received 2nd Moderna dose at 21 days/ one week early; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Given the shot one week early to a patient/received 2nd Moderna dose at 21 days/ one week early) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053C21A and 053C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Jul-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Given the shot one week early to a patient/received 2nd Moderna dose at 21 days/ one week early). On 13-Jul-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Given the shot one week early to a patient/received 2nd Moderna dose at 21 days/ one week early) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No Treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Follow-up received on 19-Jul-2021 contains significant information. The second dose start date of the Moderna vaccine was added. The event was updated. On 20-Jul-2021: Follow-up received on 20-Jul-2021 contains significant information. The patient demographics (Patient's initials, DOB) were added. The start date and Lot no. of first and second Moderna vaccine was added. The expiry date of the second dose was added.
1 WEEK AFTER RECEIVING FIRST MODERNA VACCINE ON UPPER LEFT ARM,  I BEGAN FEELING A TIGHTENING IN MY UPPER LEFT ARM AND A TINGLING SENSATION DOWN MY FOREARM (LIKE THERE'S SOMETHING ALIVE MOVING),  OCCURRING SEVERAL TIMES A DAY BUT NOT ALL THE TIME (4 TO 5 TIMES IN A DAY). THIS IS STILL OCCURRING AR THIS TIME. I'M SCHEDULED TO TAKE THE 2ND VACCINE ON 03/29/2021. I WANT TO KNOW IF I SHOULD TAKE IT. PLEASE ADVISE
G47.33 OBSTRUCTIVE SLEEP APNEA 5/18/2022 PANCYTOPENIA I95.9 HYPOTENSION 4/20/2022 PANCYTOPENIA G47.33 OBSTRUCTIVE SLEEP APNEA 5/18/2022 PANCYTOPENIA I95.9 HYPOTENSION 4/20/2022 PANCYTOPENIA G47.33 OBSTRUCTIVE SLEEP APNEA 5/18/2022 ACUTE LYMPHOID LEUKEMIA I95.9 HYPOTENSION 4/20/2022 ACUTE LYMPHOID LEUKEMIA
MOTHER REPORTS SON PRESENTED COMPLAINTS OF TENDERNESS OF LDT WITH REDNESS  MEASURING APPROX AT TIME OF REPORTING 30 MM X 40 MM SURROUNDED BY LARGE REDDNESS AREA. NO OPEN AREAS NOTED.  MOTHER/CHILD DENIES ANY SOB OR DYSPNEA; OR CHEST PAIN.  NO HISTORY OF ASTHMA.  MOTHER REPORTS THAT SHE GAVE CHILD 1 ALEVE FOR COMPLAINT OF HEADACHE ON 10/22/09 AT APPROX 4 PM AFTER RETURN FROM SCHOOL.  CHILD RECEIVED VZV ON 10/21 AND WAS INSTRUCTED NOT AVOID USE OF ASA OR MOTRIN PRODUCT BY VACCINE ADMINISTRATOR, RN AT TIME OF ADMINISTRATION.  MOTHER REPORTS REDNESS TO BEGIN YESTERDAY EVENING
Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Mild, Systemic: Shakiness-Mild, Additional Details: pt was nervous before administration, cited fear of needles. rph tried to relax pt with breathing exercises, pt seemed okay, shot was administered and he stated he felt good. rph let pt sit in consultation room a moment before instructing pt to have a seat in the waiting area, rph was consulting at drive thru when tech called over stating pt fell out of chair and hit his head, pt was on the floor w/abrasion over left eye. rph instructed tech to call EMS, rescue arrived and pt declined ambulance
Covid-19; Covid-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45-year-old male patient received BNT162b2 (BNT162B2), on 13Apr2021 as dose 1, single (Lot number: EW0164), in left arm and on 04May2021 as dose 2, single (Lot number: EW0173) at the age of 44 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 09Dec2021 as dose 3 (booster), single (Lot number: 058H21A), in left arm. The patient had no relevant medical history. No known allergies. No other medication in 02 weeks. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Covid-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of covid-19. Brand was Pfizer Paxlovid. Treatment start date was 09Apr2022 and treatment stop date was 13Apr2022.  Clinical course: No treatment for AE. Reoccurrence of testing positive for COVID-19 less than two weeks after ending Paxlovid treatment of initial infection.
Patient called public health clinic 10/5/2022 to cancel appointment for 2nd dose of Novavax because was instructed by her cardiologist not to get r/t was hospitalized for pericarditis after receiving first dose. First dose was given 9/15/2022 and went to ER 9/20/2022 with chest pain. DC from hospital on 9/23/2022.  Continues having chest pain while at home and was awaiting return call from cardiologist on 10/5/2022.  VAERS information given to Patient and cardiologist office by this nurse.
This case was reported by a consumer via interactive digital media and described the occurrence of whooping cough in a 9-month-old male patient who received DTP (A or W not known) for prophylaxis. On an unknown date, the patient received the 1st dose of DTP (A or W not known). On an unknown date, 14 days after receiving DTP (A or W not known), the patient experienced whooping cough (serious criteria GSK medically significant). On an unknown date, the outcome of the whooping cough was unknown. It was unknown if the reporter considered the whooping cough to be related to DTP (A or W not known). Additional information received as follows: The age at vaccination was not reported. The case was reported by the patient's father. The patient had whooping cough exactly 14 days (the incubation period) after his First DPT shot (Diphtheria, Pertussis which was whooping cough, and Tetanus). The patient contracted Whooping Cough from that shot. The patient did not have any of the most dangerous reactions because the patient's father took him to the physician at the first sign, but it was scary at the reporting time. The first 48 hours were terrible. The patient did not get another vaccine. For the patient until he started school and then he was afraid. He was all right but even so vaccinations make the patient's father nervous.
Patient states that she had some mild tingling in left arm, same arm where she got the Moderna vaccine.
Immediate severe pain, burning and throbbing sensation, followed by gradual paralysis of 1st the injected limb, then the other side, as well as her respiratory system. Pt is now on ventilator, suffering from upper body paralysis. Has permanent motor neuron disease.
Patient developed high D-dimer and blood clots immediately after vaccination.  Kidney failure followed shortly thereafter.  Went into hypertensive cardiac arrest approximately 3 weeks later.  All started with vaccination.
10-19-21, Pt came with c/o post vaccination malaise and worsening fatigue 7 days post immunization.  11-4-21 follow up with abnormal bruising, continued fatigue/malaise, and abnormal SQ nodule Rt antecubital area.
Fever up to 103, chills, body aches, headaches , tiredness. Day 3 afterwards injection arm is severely swollen, hot and red. (Covid arm). The Covid arm happened after all 3 doses.
I started having migraines at the end of May 2021 that were more severe and I have never experienced that before. It got to a point where I had 4 to 5 migraines a day. The doctor prescribed me  Maxalt 20mg 2 per episode for the migraines. I'm exceeding 60 pills a month that has been prescribed due to me having so many migraines. They started to happen in the day but now they happen at night. My right eye starts watering and the migraines would last 5 to 6 hours twice at night. I did get covid back in November of 2019. I had migraines then went I got covid but not as severe. I used to work 9 or 10 hours a day but now I am restricted to only 5 to 6 hours now. A heating pad and the Maxalt medicine helps with the migraines, but light on my head makes migraines worst. I'm wanting to know if there are any trials for any studies for getting rid of the migraines. The reason that I decided to get the vaccine was because I contracted covid in November 2019 that had turned into pneumonia and I am immunocompromised.
Received flu vaccination at 12:30PM. At home that evening, patient developed maculopapular rash bilaterally on wrists and the next morning woke up with rash bilaterally on arms. The rash continued to spread to torso and neck. No difficulty breathing. No swelling in throat or mouth.
Very poor sleep; Sense of dread/  Worried that she was dying and heart was going to explode; Heart palpitating and racing; Very tired; Soreness in arm where the vaccine was injected; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN; lot unknown reason: other) via an unspecified route of administration on an unknown date (at the age of 33-year-old) as a single dose for COVID-19 immunisation. The patient medical history included bronchitic asthma, ventricular septal defect and heart murmur. The patient was allergic to latex. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Jun2021 at 05:15, the patient experienced very poor sleep, felt a sense of dread and then heart palpitating and racing, which woke her up. She was worried that she was dying and heart was going to explode, very tired and worried. This has been her only noticeable side effect besides soreness in her arm where the vaccine was injected. The clinical outcome of the events very poor sleep, felt a sense of dread and then heart palpitating and racing, which woke her up, she was worried that she was dying and heart was going to explode very tired and worried soreness in arm where the vaccine was injected was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
itchy throat; headache; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of THROAT IRRITATION (itchy throat) and HEADACHE (headache) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced THROAT IRRITATION (itchy throat) and HEADACHE (headache). At the time of the report, THROAT IRRITATION (itchy throat) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered THROAT IRRITATION (itchy throat) and HEADACHE (headache) to be probably related.    No concomitant product was reported.  Patient's treatment information include Benadryl 25 mg po. She was monitored an additional 30 minutes at which time, she was doing well and instructed to follow-up with our onsite nurse as needed.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow up was received on 07 may 2021 included no new information.
Headache, swelling, neck pain, high temp fever, pneumonia, loss of state and smell, swelling of lymph nodes.
p/vax approx 230PM on 6/1/99 & same evening began w/generalized aches;by next morning 6/2/99 t102.8;by 2PM T104.2;medicated w/APAP;temp broke next morning & cont improvement on 6/3/99;resolved;
this report is overdose;1 of 2 pts vaxed w/pneumovax & approx 1 month later JAN95 was re-vaxed w/pnu-immune;pt exp red,sore arm,warm to touch,also devel a fever
Headache, Diarrhea & NauseaVomiting missed work following the second dose due to the above adverse effects
fatigue, slight chills, low-grade fever, mild headache  about 19 hrs after injection, lasting overnight. 2 days after injection normal temperature, no headache, chills or fatigue.
Pt. had severe rash that had tripled in size since he received the vaccination - starting at the injection site and going down into the armpit - slight swelling - pt. very itchy and not comfortable - no swelling of lips or throat. Given 50 mg of BENADRYL.
Medication suspected of leading to the adverse reaction: Pneumococcal Conjugate Vaccine- 0.5/IM- Result of the reaction on the level of care: Drug therapy initiated/changed Incident Description patient had PNEUMOVAX, shingles and Tdap vaccines on 6/5/12. Patient had some local soreness. 5-6 days after injection began to have warmth and redness at lateral arm site seen in office 6/12/12- +cellulitis at lateral arm site and begun on oral antibiotics.
inability to extend finger, abd cramping & diarrhea noc of 2nd vax;had cat bite 27MAY95;wound cleaned @ time;had 9 day interval between 1st & 2nd dose;asymptomatic in AM next day 25AUG97 f/u pt reported GI pain (cramps), n/v;
Headache, tremor, nausea.  "Falling star" in Rt eye.  Recovered completely in 24 hrs.
Patient appeared flushed and began to be hyper ventilating  the post vaccination waiting room after receiving their first dose of the Moderna Vaccine
There were no reactions/adverse effects; a child in their clinic who inadvertently received PROQUAD and MMR-II at the same time; a child in their clinic who inadvertently received PROQUAD and MMR-II at the same time; This spontaneous report was received from a pharmacist referring to a 1-year-old female patient. Information regarding the patient's concurrent conditions, medical history, historical drugs and concomitant therapies was not provided.   On 23-OCT-2020, the patient inadvertently received at the same time measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) intramuscularly for immunisation (strength, dose, frequency, lot number and expiration date were not reported for neither). There were no reactions/adverse effects at the time of the event.